Amedeo Smart

Free Medical Literature Service


 

Amedeo

Anemia

  Free Subscription

Articles published in
Hemoglobin
    August 2022
  1. AMARASINGHA AADS, Silva HJRL, Perera PS, Premawardhena AP, et al
    Anemia in Sri Lanka: A Literature Review.
    Hemoglobin. 2022 Aug 24:1-11. doi: 10.1080/03630269.2022.2096460.
    >> Share

    May 2022
  2. MANCO L, Santos R, Rocha C, Relvas L, et al
    Hb F Levels in beta-Thalassemia Carriers and Normal Individuals: Known and Unknown Quantitative Trait Loci in the beta-Globin Gene Cluster.
    Hemoglobin. 2022;46:168-175.
    >> Share

  3. REN ZM, Xing ZH, Chen SL, Fu XY, et al
    Identification of a Novel Hb H Disease with Glucose-6-Phosphate Dehydrogenase Deficiency Using Whole Genome Sequencing.
    Hemoglobin. 2022;46:160-163.
    >> Share

  4. KURUCU B, Fettah A, Capkinoglu E, Oner N, et al
    Dynamic Thiol-Disulfide Homeostasis in Children With beta-Thalassemia Trait.
    Hemoglobin. 2022;46:164-167.
    >> Share

  5. KHAMPHIKHAM P, Sakkhachornphop S, Pongsatha S, Pornprasert S, et al
    Strong Positive Dichlorophenolindophenol Precipitation Suggests Hb Dhonburi (or Hb Neapolis) (HBB: c.380T>G) Inheritance in a Couple at Risk for Severe beta-Thalassemia.
    Hemoglobin. 2022;46:184-186.
    >> Share

  6. PARSASEFAT M, Safarpour H, Nomiri S, Miri-Moghaddam E, et al
    Treatment with Hydroxyurea Leads to Fetal Hemoglobin Reactivation through CA1 and LIN28B Genes: An In Vitro Study.
    Hemoglobin. 2022;46:153-159.
    >> Share

  7. MORADI K, Aznab M, Azimi A, Biglari M, et al
    alpha-Thalassemia Mutations in Ilam Province, West Iran.
    Hemoglobin. 2022;46:147-152.
    >> Share

    March 2022
  8. VARELAS C, Gavriilaki E, Sakellari I, Klonizakis F, et al
    Hemoglobinopathies and COVID-19: The Experience of a Center in Northern Greece.
    Hemoglobin. 2022;46:143-145.
    >> Share

  9. MANGANAS K, Delicou S, Xydaki A, Koskinas J, et al
    Iron Chelators, Such as Deferasirox, When Combined With Hydroxyurea, Provide an Additional Benefit of Iron Chelation in Patients Receiving Chronic Transfusion Therapy.
    Hemoglobin. 2022;46:114-117.
    >> Share

  10. ZARKADA E, Yfanti E, Teli A, Balassopoulou A, et al
    Rare Pathogenic beta(0)-Thalassemia Mutation, Codon 7 (GAG>TAG) (HBB: c.22G>T). Report of the First Two Cases in Albanian Immigrants of Northern Greece.
    Hemoglobin. 2022;46:140-142.
    >> Share

  11. SAHA D, Chowdhury PK, Panja A, Pal D, et al
    Effect of deletions in the alpha-globin gene on the phenotype severity of beta-thalassemia.
    Hemoglobin. 2022;46:118-123.
    >> Share

  12. EFSTATHIOU A, Boutou E, Teli A, Drikos I, et al
    A New Hemoglobin Variant, Hb Natal (HBA1: c.423C>A), Found in a Greek Family.
    Hemoglobin. 2022;46:132-136.
    >> Share

  13. KITTIPOOM T, Tantiworawit A, Punnachet T, Hantrakun N, et al
    The Long-Term Efficacy of Deferiprone in Thalassemia Patients With Iron Overload: Real-World Data from the Registry Database.
    Hemoglobin. 2022;46:75-80.
    >> Share

  14. JIANG F, Chen GL, Li J, Tang XW, et al
    beta-Thalassemia Intermedia Caused by the beta-Globin Gene 3' Untranslated Region: Another Case Report.
    Hemoglobin. 2022;46:137-139.
    >> Share

  15. KARAKAYA T, Silan F, Ozdemir O
    A New Mutation, Hb A2-Canakkale [delta10(A7)Ala-->Val; HBD: c.32C>T], and Other Well-Known delta Variants Identified in a Selected Cohort with Low Hb A2 Levels.
    Hemoglobin. 2022;46:87-90.
    Val; HBD: c.32C>T], and Other Well-Known delta Variants Identified in a Selected Cohort with Low Hb A2 Levels.&body=KARAKAYA T, Silan F, Ozdemir O. A New Mutation, Hb A2-Canakkale [delta10(A7)Ala-->Val; HBD: c.32C>T], and Other Well-Known delta Variants Identified in a Selected Cohort with Low Hb A2 Levels. Hemoglobin. 2022;46:87-90. https://www.ncbi.nlm.nih.gov/m/pubmed/35930292" ALT="Email" TITLE="Email"> --> >> Share

  16. ZAMAN BA, Ibrahim SA
    Hepcidin-to-Ferritin Ratio as an Early Diagnostic Index of Iron Overload in beta-Thalassemia Major Patients.
    Hemoglobin. 2022;46:106-113.
    >> Share

  17. BICILIOGLU Y, Bal A, Demir Yenigurbuz F, Ergonul E, et al
    Noninvasive Hemoglobin Measurement Reduce Invasive Procedures in Thalassemia Patients.
    Hemoglobin. 2022;46:95-99.
    >> Share

  18. BINDING A
    Bringing Sickle Cell Disease Care Closer to Home: Feasibility and Efficacy of a Quality Improvement Initiative at a Community Hospital.
    Hemoglobin. 2022;46:91-94.
    >> Share

    January 2022
  19. PAIBOONSUKWONG K, Jopang Y, Winichagoon P, Fucharoen S, et al
    Thalassemia in Thailand.
    Hemoglobin. 2022;46:53-57.
    >> Share

  20. CHONG SC, Metassan S, Yusof N, Idros R, et al
    Thalassemia in Asia 2021 Thalassemia in Brunei Darussalam.
    Hemoglobin. 2022;46:15-19.
    >> Share

  21. KHAING AA, Myint PP, Paiboonsukwong K, Win N, et al
    Clinical Severity of beta-Thalassemia Pediatric Patients in Myanmar.
    Hemoglobin. 2022;46:66-70.
    >> Share

  22. COLAH RB, Seth T
    Thalassemia in India.
    Hemoglobin. 2022;46:20-26.
    >> Share

  23. PREMAWARDHENA AP, Madushanka HDP
    Thalassemia in Sri Lanka.
    Hemoglobin. 2022;46:71-73.
    >> Share

  24. CHOWDHURY MA, Sultana R, Das D
    Thalassemia in Asia 2021 Overview of Thalassemia and Hemoglobinopathies in Bangladesh.
    Hemoglobin. 2022;46:7-9.
    >> Share

  25. SOPHAL C
    Thalassemia Status in Cambodia.
    Hemoglobin. 2022;46:10-11.
    >> Share

  26. FUCHAROEN S, Ping C, Paiboonsukwong K
    Introduction to the Special Issue.
    Hemoglobin. 2022;46:1.
    >> Share

  27. KHALIQ S
    Thalassemia in Pakistan.
    Hemoglobin. 2022;46:12-14.
    >> Share

  28. YUSON ED, Naranjo MLT
    Thalassemia in the Philippines.
    Hemoglobin. 2022;46:36-38.
    >> Share

  29. WAHIDIYAT PA, Sari TT, Rahmartani LD, Iskandar SD, et al
    Thalassemia in Indonesia.
    Hemoglobin. 2022;46:39-44.
    >> Share

  30. PHENGSAVANH A, Sengchanh S, Souksakhone C, Souvanlasy B, et al
    Current Status of Thalassemia in Lao People's Democratic Republic.
    Hemoglobin. 2022;46:58-61.
    >> Share

  31. BACH KQ, Nguyen HTT, Nguyen TH, Nguyen MB, et al
    Thalassemia in Viet Nam.
    Hemoglobin. 2022;46:62-65.
    >> Share

  32. ALWI ZB, Syed-Hassan SR
    Thalassemia in Malaysia.
    Hemoglobin. 2022;46:45-52.
    >> Share

  33. CHEN P, Lin WX, Li SQ
    THALASSEMIA in ASIA 2021: Thalassemia in Guangxi Province, People's Republic of China.
    Hemoglobin. 2022;46:33-35.
    >> Share

  34. ANURATHAPAN U, Pakakasama S, Songdej D, Pongphitcha P, et al
    Haploidentical Hematopoietic Stem Cell Transplantation in Thalassemia.
    Hemoglobin. 2022;46:2-6.
    >> Share

  35. YADAV SS, Panchal P, Menon KC
    Prevalence and Management of beta-Thalassemia in India.
    Hemoglobin. 2022;46:27-32.
    >> Share

    November 2021
  36. MELVIN RG, Liederman Z, Arya S, Rotin L, et al
    A Case of Fat Embolism Syndrome with Cerebral Involvement in Sickle Cell Anemia.
    Hemoglobin. 2021 Nov 8:1-5. doi: 10.1080/03630269.2021.1990081.
    >> Share

  37. DEHURY S, Mohanty PK, Patel S, Meher S, et al
    Profiling of 35 Cases of Hb S/Hb E (HBB: c.20A>T/HBB: c.79G>a), Disease and Association with alpha-Thalassemia and beta-Globin Gene Cluster Haplotypes from Odisha, India.
    Hemoglobin. 2021;45:380-386.
    >> Share

  38. CHAN NCN, Wong THY, Cheng KCK, Chan NPH, et al
    An Evaluation for the Causes of Reduced Hb A2 and the Molecular Characterization of HBD Variants in Hong Kong.
    Hemoglobin. 2021;45:387-391.
    >> Share

  39. HAGHPANAH S, Hosseini-Bensenjan M, Sayadi M, Karimi M, et al
    Incidence Rate of COVID-19 Infection in Hemoglobinopathies: A Systematic Review and Meta-analysis.
    Hemoglobin. 2021;45:371-379.
    >> Share

  40. FARRA C, Abdouni L, Souaid M, Awwad J, et al
    The Spectrum of beta-Thalassemia Mutations in the Population Migration in Lebanon: A 6-Year Retrospective Study.
    Hemoglobin. 2021;45:365-370.
    >> Share

  41. TSITSIKAS DA, Kamal M, Braimoh A, Benson S, et al
    Hb S (HBB: c.20A>T) Characteristics by High Performance Liquid Chromatography in Patients with Sickle Cell Disease Receiving the Novel Agent Voxelotor.
    Hemoglobin. 2021;45:355-357.
    >> Share

  42. ALIYEVA G, Abdulalimov E, Asadov C, Mammadova T, et al
    First Report of beta-Thalassemia Intermedia in a Patient Compound Heterozygous for -92 (C>T) and Codons 36/37 (-T) Mutations.
    Hemoglobin. 2021;45:347-348.
    >> Share

    September 2021
  43. HUANG LF, Yu LL, Nikuze L, Singh S, et al
    Spectrum of beta-Thalassemia Mutations in Some Areas of Guangxi Zhuang Autonomous Region of Southern China: A Study on a Pediatric Population Aged 0-15 Years.
    Hemoglobin. 2021;45:318-321.
    >> Share

  44. HAMALI HA
    Glucose-6-Phosphate Dehydrogenase Deficiency: An Overview of the Prevalence and Genetic Variants in Saudi Arabia.
    Hemoglobin. 2021;45:287-295.
    >> Share

  45. YADAV DD, Jamwal M, Singh N, Sharma R, et al
    Hb Mizuho (HBB: c.206T>C): Pitfalls of Screening Tests in an Unstable Hemoglobin Variant Diagnosed after Targeted Next-Generation Sequencing.
    Hemoglobin. 2021;45:338-340.
    >> Share

  46. RUENGDIT C, Punyamung M, Khamphikham P, Pongpunyayuen P, et al
    Multiplex Quantitative Real-Time Polymerase Chain Reaction and High-Resolution Melting Analysis for Identification of a Couple At-Risk of Having a Newborn with Severe Thalassemia.
    Hemoglobin. 2021;45:309-313.
    >> Share

  47. TRUTTMANN R, Schmidt A, Hartmann B, Rusch S, et al
    Description of Hb Evora (HBA2: c.106T>C) on an Unexpected Allele in a Swiss Family.
    Hemoglobin. 2021;45:314-317.
    >> Share

  48. ZAHRA A, Ragab A, Al-Abboh H, Ismaiel A, et al
    Perforated Duodenal Ulcer Associated with Deferasirox in a Child with beta-Thalassemia Major.
    Hemoglobin. 2021;45:335-337.
    >> Share

  49. CHEN HQ, Wu LS, Jiang F, Li DZ, et al
    Dominant beta-Thalassemia Phenotype Caused by Hb Dieppe (HBB: c.383A>G): Another Case Report.
    Hemoglobin. 2021;45:329-331.
    >> Share

  50. SEN A, Seenappa V, Chakrabarti P, Dolai TK, et al
    First Report of the 3'-Untranslated Region +1506 (A>C) [NM_000518.5: c.*32A>C] mutation on the beta-Globin Gene in the Indian Population.
    Hemoglobin. 2021;45:325-328.
    >> Share

  51. DELICOU S, Aggeli K, Magganas K, Patsourakos D, et al
    Acute Chest Syndrome in Sickle Cell Disease: Clinical Presentation and Outcomes. The Experience of a Single Thalassemia and Sickle Cell Unit in a University Hospital.
    Hemoglobin. 2021;45:303-308.
    >> Share

  52. HAGHPANAH S, Hosseini-Bensenjan M, Sayadi M, Karimi M, et al
    The Prevalence of Hypothyroidism among Patients With beta-Thalassemia: A Systematic Review and Meta-Analysis of Cross-Sectional Studies.
    Hemoglobin. 2021;45:275-286.
    >> Share

  53. KHALIL MSM, Timbs AT, Henderson SJ, Schuh A, et al
    Eleven Cases of Hb J-Paris-I [HBA2: c.38C>A (or HBA1)]: A Stable alpha Chain Variant Elutes in the P3 Window on High-Performance Liquid Chromatography.
    Hemoglobin. 2021;45:322-324.
    >> Share

  54. TRIPATHY I, Panja A, Dolai TK, Mallick AK, et al
    Comparative Efficacy and Safety Between Deferiprone and Deferasirox with Special Reference to Serum Ferritin Level and Cardiac Function in Bengali beta-Thalassemia Major Children.
    Hemoglobin. 2021;45:296-302.
    >> Share

    July 2021
  55. ATROSHI SD, Al-Allawi NAS, Eissa AA
    Updated Molecular Spectrum of beta-Thalassemia Mutations in Duhok Province, Northern Iraq: Ethnic Variation and the Impact of Immigration.
    Hemoglobin. 2021;45:239-244.
    >> Share

  56. PERERA S, Allen A, Rees DC, Premawardhena A, et al
    Pitfalls in the Diagnosis of beta-Thalassemia Intermedia.
    Hemoglobin. 2021;45:265-268.
    >> Share

  57. KHALIL MSM, Timbs AT, Henderson SJ, Schuh A, et al
    Eight Cases of Hb Winnipeg [HBA2: c.226G>T (or HBA1)]: A Detailed Study.
    Hemoglobin. 2021;45:256-258.
    >> Share

  58. ETEMAD K, Mohseni P, Aghighi M, Bahadorimonfared A, et al
    Quality of Life and Related Factors in beta-Thalassemia Patients.
    Hemoglobin. 2021;45:245-249.
    >> Share

  59. UCUCU S, Karabiyik T, Azik FM
    IVS-II-16 (G>C) (HBB: c.315+16G>C) or IVS-II-666 (C>T) (HBB: c.316-185C>T) Mutations Trigger an Hb S (HBB: c.20A>T)/beta(+)-Thalassemia Phenotype in an Hb S Trait Patient.
    Hemoglobin. 2021;45:225-227.
    >> Share

  60. IDRIS IM, Yusuf AA, Gwarzo DH, Kurawa MS, et al
    High Systolic Blood Pressure, Anterior Segment Changes and Visual Impairment Independently Predict Sickle Cell Retinopathy.
    Hemoglobin. 2021;45:228-233.
    >> Share

  61. MARTIN G, Grimholt RM, Le D, Bechensteen AG, et al
    Hb Calgary (HBB: c.194G>T): A Highly Unstable Hemoglobin Variant with a beta-Thalassemia Major Phenotype.
    Hemoglobin. 2021;45:215-219.
    >> Share

  62. RAFAT M, Allamehzadeh Z, Shekari M, Afsa M, et al
    The Effect of HBB: c.-121C>T Variant [-71 (C>T)] on the beta-Globin Promoter: Case Series Study.
    Hemoglobin. 2021;45:234-238.
    >> Share

  63. JIANG F, Tang XW, Li J, Zhou JY, et al
    Hb Lepore-Hong Kong: First Report of a Novel delta/beta-Globin Gene Fusion in a Chinese Family.
    Hemoglobin. 2021;45:220-224.
    >> Share

    June 2021
  64. ANAH MU, Nlemadim AC, Uzomba CI, Ineji EO, et al
    Prolonged QTc Interval in Nigerian Children with Sickle Cell Anemia.
    Hemoglobin. 2021 Jun 10:1-6. doi: 10.1080/03630269.2021.1937207.
    >> Share

    May 2021
  65. ZHAO Q, Zhao SM, Zhang X, Chen SP, et al
    Detection of the HBB: c.393T>G Mutation in Two Patients with Hypochromic Microcytic Anemia.
    Hemoglobin. 2021 May 25:1-4. doi: 10.1080/03630269.2021.1929307.
    >> Share

  66. BROWN BJ, Madu A, Sangeda RZ, Nkya S, et al
    Utilization of Pneumococcal Vaccine and Penicillin Prophylaxis in Sickle Cell Disease in Three African Countries: Assessment among Healthcare Providers in SickleInAfrica.
    Hemoglobin. 2021;45:163-170.
    >> Share

  67. TSOLAKIDIS V, Vlachaki E, Papaioannou M, Pantelidou D, et al
    Total Annual Economic Burden of Patients with Sickle Cell Disease in Steady State in Greece.
    Hemoglobin. 2021;45:143-149.
    >> Share

  68. MOORE JA, Pullon BM, Wang D, Brennan SO, et al
    Hb Tacoma: G>T or G>C, and Does It Matter?
    Hemoglobin. 2021;45:203-206.
    >> Share

  69. SOOD R, Rastogi P, Bansal D, Das R, et al
    An Autopsy Case of beta-Thalassemia Major Illuminating the Pathological Spectrum of the Disease.
    Hemoglobin. 2021;45:180-185.
    >> Share

  70. ATROSHI SD, Al-Allawi N, Chui DHK, Najmabadi H, et al
    A Novel beta(0)-Thalassemia Mutation, HBB: c.356_357delTT [Codon 118 (-TT)] in an Iraqi Kurd.
    Hemoglobin. 2021;45:212-214.
    >> Share

  71. SAENSUWANNA A, Penglong T, Srinoun K
    Upregulation of miR-214 Mediates Oxidative Stress in Hb H Disease via Targeting of ATF4.
    Hemoglobin. 2021;45:197-202.
    >> Share

  72. RUJEERAPAIBOON N, Tantiworawit A, Piriyakhuntorn P, Rattanathammethee T, et al
    Correlation Between Serum Ferritin and Viral Hepatitis in Thalassemia Patients.
    Hemoglobin. 2021;45:175-179.
    >> Share

  73. THEPPORNPITAK K, Trakarnsanga B, Lauhasurayotin S, Poparn H, et al
    A Study to Assess and Improve Adherence to Iron Chelation Therapy in Transfusion-Dependent Thalassemia Patients.
    Hemoglobin. 2021;45:171-174.
    >> Share

  74. LUO LP, Ma L, Lin SB, Huang JG, et al
    Elevated Hb A2 is Not Always Indicative of beta-Thalassemia.
    Hemoglobin. 2021;45:186-190.
    >> Share

  75. SAHA J, Panja A, Nayek K
    The Prevalence of HBB Mutations among the Transfusion-Dependent and Non Transfusion-Dependent Hb E/beta-Thalassemia Children in a Tertiary Center of West Bengal, India.
    Hemoglobin. 2021;45:157-162.
    >> Share

  76. TIAN Q, Lei YL, Xu LL, Li DZ, et al
    First Report of Nondeletional Hb H Disease Caused by an alpha2-Globin Gene Mutation: HBA2: c.184A>T.
    Hemoglobin. 2021;45:210-211.
    >> Share

    March 2021
  77. ALIMOHAMMADI-BIDHENDI S, Azadmehr S, Razipour M, Zeinali S, et al
    Regulatory Mutation Study in Cases with Unsolved Hypochromic Microcytic Anemia and alpha-Major Regulatory Element Haplotype Analysis in Iran.
    Hemoglobin. 2021 Mar 27:1-4. doi: 10.1080/03630269.2021.1882482.
    >> Share

  78. OGU UO, Reyes Gil M, Tolu SS, Acharya SA, et al
    First Report of Compound Heterozygosity for Hb S (HBB: c.20A>T) and Hb Haringey (HBB: c.131A>G).
    Hemoglobin. 2021;45:136-139.
    >> Share

  79. YIN Z, Hao Y, Huang X, Chen X, et al
    A Novel Mutation at HBA1: c.349G>T Causing alpha-Thalassemia in a Chinese Family.
    Hemoglobin. 2021;45:94-96.
    >> Share

  80. MARTINEZ VILLEGAS O, Mendoza-Melendez D, Trueba-Gomez R, Rosenfeld-Mann F, et al
    Analysis of a Novel Mexican Variant of the HBB Gene Associated with beta-Thalassemia Using Bioinformatic Tools.
    Hemoglobin. 2021;45:87-93.
    >> Share

  81. INATI A, Al Alam C, El Ojaimi C, Hamad T, et al
    Clinical Features and Outcome of Sickle Cell Disease in a Tertiary Center in Northern Lebanon: A Retrospective Cohort Study in a Local, Hospital-Associated Registry.
    Hemoglobin. 2021;45:80-86.
    >> Share

  82. PANICHCHOB P, Iamdeelert P, Wongsariya P, Wongsariya P, et al
    Molecular Spectrum of beta-Thalassemia Mutations in Central to Eastern Thailand.
    Hemoglobin. 2021;45:97-102.
    >> Share

  83. SHARIFI F, Safizadeh H, Bahrampour A
    Development of the Quality of Life Questionnaire (SF-36) for Patients with beta-Thalassemia Major and beta-Thalassemia Intermedia Based on Extended Rasch Analysis.
    Hemoglobin. 2021;45:119-123.
    >> Share

  84. ZARDKHONI SZ, Moghaddam AG, Rad F, Ghatee MA, et al
    Serum Zinc Level in beta-Thalassemia Major: A Retrospective Study in Southwest Iran.
    Hemoglobin. 2021;45:103-106.
    >> Share

  85. ZHAO YL, Lin QF, He XW, Li YQ, et al
    Hb Hezhou [beta64(E8)Gly-->Ser; HBB: c.193G>A]: A Novel Variant on the beta-Globin Gene.
    Hemoglobin. 2021;45:133-135.
    Ser; HBB: c.193G>A]: A Novel Variant on the beta-Globin Gene.&body=ZHAO YL, Lin QF, He XW, Li YQ, et al. Hb Hezhou [beta64(E8)Gly-->Ser; HBB: c.193G>A]: A Novel Variant on the beta-Globin Gene. Hemoglobin. 2021;45:133-135. https://www.ncbi.nlm.nih.gov/m/pubmed/33843396" ALT="Email" TITLE="Email"> --> >> Share

  86. SOLTANI D, Fakhrzadeh H, Sharifi F, Mahmoudi MJ, et al
    Surrogate Markers of Subclinical Atherosclerosis and Its Associated Factors in Patients with beta-Thalassemia Major.
    Hemoglobin. 2021;45:107-111.
    >> Share

  87. COLAH RB, Nadkarni AH, Gorakshakar AC, Sawant PM, et al
    The Changing Trends in Prenatal Diagnosis of Hemoglobinopathies in India: The Quest of a Single Center to Reduce the Burden of Disease over Three Decades.
    Hemoglobin. 2021;45:112-118.
    >> Share

  88. RUENGDIT C, Khamphikham P, Jinorose N, Pornprasert S, et al
    Hb Bart's Hydrops Fetalis Syndrome and Hb H Disease Caused by Deletional Chiang Rai (- -(CR)) alpha(0)-Thalassemia in Two Unrelated Thai Families.
    Hemoglobin. 2021;45:75-79.
    >> Share

  89. WANG RY, Jiang F, Xu LL, Li DZ, et al
    Mild alpha-Thalassemia Caused by a Mosaic alpha-Globin Gene Mutation.
    Hemoglobin. 2021;45:140-141.
    >> Share

    January 2021
  90. MEHER S, Mohanty PK, Patel S, Das K, et al
    Haptoglobin Genotypes Associated with Vaso-Occlusive Crisis in Sickle Cell Anemia Patients of Eastern India.
    Hemoglobin. 2021 Jan 3:1-7. doi: 10.1080/03630269.2020.1801459.
    >> Share

  91. ZAFARI M, Rad MTS, Mohseni F, Nikbakht N, et al
    beta-Thalassemia Major and Coronavirus-19, Mortality and Morbidity: a Systematic Review Study.
    Hemoglobin. 2021;45:1-4.
    >> Share

  92. CHEN X, Lin Z, Hu J, Chen S, et al
    Report of Two Novel Thalassemia Variants, HBB: c.181delG and HBA1: c.121_126delAAGACC, in Chinese Individuals.
    Hemoglobin. 2021;45:52-55.
    >> Share

  93. LIU L, Sun Y, Chen S, Yu C, et al
    Identification of Two Novel Thalassemia Variants, HBA1: c.263delA and HBA2: c.376dupC, in Chinese Individuals.
    Hemoglobin. 2021;45:49-51.
    >> Share

  94. AL-ZUHAIRY SH, Darweesh MA, Othman MA
    Relation of Serum Ferritin Level with Serum Hepcidin and Fucose Levels in Children with beta-Thalassemia Major.
    Hemoglobin. 2021;45:69-73.
    >> Share

  95. BALLAS SK, Riddick-Burden G, Congdon-Martin E
    Determinants of the Outcome of the Transition of Children with Sickle Cell Disease to Adult Programs.
    Hemoglobin. 2021;45:62-65.
    >> Share

  96. TARIQ A, Khurshid S, Sajjad M
    Evaluation of the High Resolution Melting Approach for Detection of beta-Thalassemia Gene Mutations.
    Hemoglobin. 2021;45:20-24.
    >> Share

  97. LIN QY, Chen DY, Kong S, Liu WQ, et al
    A Rare Case of Hb H Disease and Systemic Lupus Erythematosus.
    Hemoglobin. 2021;45:66-68.
    >> Share

  98. WANG WJ, Ding ZX, Zhang HM, Tao TT, et al
    Identification of a Novel beta-Thalassemia Mutation at Codon 130 (+T) (HBB: c.391insT) in Han Chinese.
    Hemoglobin. 2021;45:46-48.
    >> Share

  99. GOLLAMUDI J, Sarvepalli S, Vadaparti Binf A, Alin T, et al
    Venous Thromboembolism in Sickle Cell Disease is Associated with Neutrophilia.
    Hemoglobin. 2021;45:56-59.
    >> Share

  100. SIGAL IR, Ciunci CA
    Case Report of Acute Splenic Sequestration Crisis in an Adult Patient with Hb S Disease and Suspected Hereditary Persistence of Fetal Hemoglobin.
    Hemoglobin. 2021;45:60-61.
    >> Share

  101. DOULGERAKI A, Fragodimitri C, Athanasopoulou H, Drakaki K, et al
    Chronic Hemolysis May Adversely Affect Skeletal Health. A Cross-Sectional Study of a Pediatric Population.
    Hemoglobin. 2021;45:30-36.
    >> Share

  102. AYDOGDU S, Toret E, Aksoy BA, Aydin MF, et al
    Comparison of Hematopoietic Stem Cell Transplantation Results in Patients with beta-Thalassemia Major from Three Different Graft Types.
    Hemoglobin. 2021;45:25-29.
    >> Share

  103. ANGASTINIOTIS M, Petrou M, Loukopoulos D, Modell B, et al
    The Prevention of Thalassemia Revisited: A Historical and Ethical Perspective by the Thalassemia International Federation.
    Hemoglobin. 2021;45:5-12.
    >> Share

  104. LIEDERMAN Z, Quartey NK, Ward R, Papadakos J, et al
    Exploration of Barriers and Facilitators to Optimal Emergency Department Care of Sickle Cell Disease: Opportunities for Patient-Physician Partnerships to Improve Care.
    Hemoglobin. 2021;45:13-19.
    >> Share

    November 2020
  105. CHOURASIA S, Kumar R, Singh MPSS, Vishwakarma C, et al
    High Prevalence of Anemia and Inherited Hemoglobin Disorders in Tribal Populations of Madhya Pradesh State, India.
    Hemoglobin. 2020 Nov 22:1-10. doi: 10.1080/03630269.2020.1848859.
    >> Share

    July 2020
  106. BALANCHIVADZE N, Kudirka AA, Askar S, Almadhoun K, et al
    Impact of COVID-19 Infection on 24 Patients with Sickle Cell Disease. One Center Urban Experience, Detroit, MI, USA.
    Hemoglobin. 2020;44:284-289.
    >> Share

    May 2020
  107. PINTO VM, Derchi GE, Bacigalupo L, Pontali E, et al
    COVID-19 in a Patient with beta-Thalassemia Major and Severe Pulmonary Arterial Hypertension.
    Hemoglobin. 2020;44:218-220.
    >> Share

    March 2020
  108. TERAN MM, Monaco ME, Lazarte SS, Haro C, et al
    Genetic Regulation of Redox Balance in beta-Thalassemia Trait.
    Hemoglobin. 2020;44:122-127.
    >> Share

  109. AL-ALI AK, Alsulaiman A, Alzahrani AJ, Obeid OT, et al
    Prevalence and Diversity of Haplotypes of Sickle Cell Disease in the Eastern Province of Saudi Arabia.
    Hemoglobin. 2020;44:78-81.
    >> Share

  110. AZIMI A, Tahmasebi S, Moradi K, Nejati P, et al
    Severe alpha-Thalassemia Due to Compound Heterozygosity for Hb Adana (alpha59 Gly>Asp) (HBA1: c.179G > A) and Codon 127 (A > T) (HBA2: c.382A > T) in an Iranian Family.
    Hemoglobin. 2020;44:139-142.
    >> Share

  111. HORRI-NACEUR A, Timson DJ
    In Silico Analysis of the Effects of Point Mutations on alpha-Globin: Implications for alpha-Thalassemia.
    Hemoglobin. 2020;44:89-103.
    >> Share

  112. SAMHA L, Sirdah MM, Reading NS, Karmi B, et al
    Molecular Understanding of Severe Cases of beta-Thalassemia in the Nablus Region, West Bank, Palestine.
    Hemoglobin. 2020;44:128-130.
    >> Share

  113. AKSU T, Coskun C, Kuskonmaz B, Unal S, et al
    Hb H Disease Diagnosed During Adolescent Pregnancy.
    Hemoglobin. 2020;44:137-138.
    >> Share

  114. AZARKEIVAN A, Cohan N, Niazkar HR, Azizi A, et al
    Hb S (HBB: c.20A>T) and alpha- and beta-Thalassemia Coinheritance in Iranian Patients.
    Hemoglobin. 2020;44:109-112.
    >> Share

  115. HALDER R, Sundaram UKD, Veetil KK, Rath A, et al
    Concomitant Existence of Paroxysmal Nocturnal Hemoglobinuria in a Patient with Hb E (HBB: c.79G>A) Trait.
    Hemoglobin. 2020;44:134-136.
    >> Share

  116. JIANG F, Xu LL, Chen GL, Zhou JY, et al
    Hematological Characteristics of Hb Constant Spring (HBA2: c.427T>C) Carriers in Mainland China.
    Hemoglobin. 2020;44:86-88.
    >> Share

  117. MANCO L, Bento C, Relvas L, Cunha E, et al
    Multi-Locus Models to Address Hb F Variability in Portuguese beta-Thalassemia Carriers.
    Hemoglobin. 2020;44:113-117.
    >> Share

  118. AL-NOOD HA, Al-Nood RM, Ghanem NS, Al-Hadi AM, et al
    Effect of the Hydoxyurea in Yemeni Transfusion-Dependent beta-Thalassemia Patients.
    Hemoglobin. 2020;44:104-108.
    >> Share

  119. ALASHKAR F, Herbstreit F, Carpinteiro A, Baum J, et al
    Veno-Venous Extracorporeal Membrane Oxygenation in Adult Patients with Sickle Cell Disease and Acute Chest Syndrome: a Single-Center Experience.
    Hemoglobin. 2020;44:71-77.
    >> Share

  120. CHEN YJ, Li YQ, Liu Q, Tang LY, et al
    A Chinese Male with Normal Hematological Indices and High Hb A2 Levels in beta-Thalassemia Trait.
    Hemoglobin. 2020;44:131-133.
    >> Share

    January 2020
  121. SEMKIU KM, Oliveira JL, Nguyen PL, Porter TR, et al
    Hb F-Wentzville [(G)gamma24(B6)Gly-->Glu; HBG2: c.74G>A, p.Gly25Glu]: An Unstable (G)gamma-Globin Variant Associated with Neonatal Hemolytic Anemia.
    Hemoglobin. 2020 Jan 27:1-3. doi: 10.1080/03630269.2020.1716002.
    >> Share

  122. SARIHI R, Amirizadeh N, Oodi A, Azarkeivan A, et al
    Distribution of Red Blood Cell Alloantibodies Among Transfusion-Dependent beta-Thalassemia Patients in Different Population of Iran: Effect of Ethnicity.
    Hemoglobin. 2020;44:31-36.
    >> Share

  123. BELISARIO AR, Carneiro-Proietti AB, Sabino EC, Araujo A, et al
    Hb S/beta-Thalassemia in the REDS-III Brazil Sickle Cell Disease Cohort: Clinical, Laboratory and Molecular Characteristics.
    Hemoglobin. 2020;44:1-9.
    >> Share

  124. MASHON RS, Das R, Dhawan R, Kakkar N, et al
    Hb Rush (HBB: c.304G>C): A Rare Variant Hemoglobin Mimicking the Hb S (HBB: c.20A>T) Variant on High Performance Liquid Chromatography.
    Hemoglobin. 2020;44:64-66.
    >> Share

  125. MIR SA, Alshehri BM, Alaidarous M, Banawas SS, et al
    Prevalence of Hemoglobinopathies (beta-Thalassemia and Sickle Cell Trait) in the Adult Population of Al Majma'ah, Saudi Arabia.
    Hemoglobin. 2020;44:47-50.
    >> Share

  126. NAZ S, Rehman SU, Shakeel M, Rehman H, et al
    Molecular Heterogeneity of beta-Thalassemia in the Kohat Region, Khyber Pakhtunkhwa Province, Pakistan.
    Hemoglobin. 2020;44:37-41.
    >> Share

  127. AL-RIYAMI AZ, Daar S, Kindi SA, Madhani AA, et al
    alpha-Globin Genotypes Associated with Hb H Disease: A Report from Oman and a Review of the Literature from the Eastern Mediterranean Region.
    Hemoglobin. 2020;44:20-26.
    >> Share

  128. ROPERO P, Arbeteta J, Nieto JM, Gonzalez FA, et al
    Nondeletional alpha-Thalassemia: Two New Mutations on the alpha2 Gene.
    Hemoglobin. 2020;44:17-19.
    >> Share

  129. VAN GAMMEREN AJ, Pelkmans L, Endschot CCWV, Roelofsen-de Beer RJAC, et al
    An Unusual Compound Heterozygosity for Hb O-Arab (HBB: c.364G>A) and Hb D-Los Angeles (HBB: c.364G>C).
    Hemoglobin. 2020;44:61-63.
    >> Share

  130. LUO H, Zou Y, Liu Y
    A Novel beta-Thalassemia Mutation [IVS-I-6 (T>G), HBB: c.92+6T>G] in a Chinese Family.
    Hemoglobin. 2020;44:55-57.
    >> Share

  131. CHEN X, Luo S, Huang J, Yuan D, et al
    Diagnosis and Prenatal Diagnosis in a Chinese Family Carrying the Rare alpha-Thalassemia Gene HBA2: c.1A>G Mutation.
    Hemoglobin. 2020;44:51-54.
    >> Share

  132. SAKAMOTO A, Nakadate H, Tada K, Yamashiro Y, et al
    A Japanese Family with the Unstable Hb Sydney (HBB: c.203T>C) Variant and Persistent Low Hemoglobin Oxygen Saturation.
    Hemoglobin. 2020;44:58-60.
    >> Share

  133. SHOUJAA A, Moasses F, Mukhalalaty Y, Murad H, et al
    Genotype/Phenotype Correlation of beta-Thalassemia in Syrian Patients: A Cross-Sectional Study.
    Hemoglobin. 2020;44:42-46.
    >> Share

  134. SAJADPOUR Z, Amini-Farsani Z, Motovali-Bashi M, Yadollahi M, et al
    Association between Different Polymorphic Markers and beta-Thalassemia Intermedia in Central Iran.
    Hemoglobin. 2020;44:27-30.
    >> Share

    December 2019
  135. MAKIS A, Georgiou I, Traeger-Synodinos J, Storino MR, et al
    A Novel epsilongammadeltabeta-Thalassemia Deletion Associated with Severe Anemia at Birth and a beta-Thalassemia Intermedia Phenotype Later in Life in Three Generations of a Greek Family.
    Hemoglobin. 2019 Dec 12:1-4. doi: 10.1080/03630269.2019.1699568.
    >> Share

    October 2019
  136. JIANG H, Jiang F, Li J, Tang F, et al
    Congenital Nonspherocytic Hemolytic Anemia Caused by Kruppel-Like Factor 1 Gene Variants: Another Case Report.
    Hemoglobin. 2019 Oct 23:1-4. doi: 10.1080/03630269.2019.1680384.
    >> Share

    May 2019
  137. ADEYEMO TA, Diaku-Akinwunmi IN, Ojewunmi OO, Bolarinwa AB, et al
    Barriers to the use of hydroxyurea in the management of sickle cell disease in Nigeria.
    Hemoglobin. 2019;43:188-192.
    >> Share

  138. CANNATA M, Cassara F, Vinciguerra M, Licari P, et al
    Double Heterozygosity for Hb Durham-N.C. (HBB: c.344T>C) [beta114(G16)Leu-->Pro] and the IVS-I-110 (HBB: c.93-21G>A) Causing a Severe beta-Thalassemia Phenotype.
    Hemoglobin. 2019;43:210-213.
    >> Share

  139. SAFAEI S, Abedi H, Parand S, Karimi M, et al
    Evaluation of the Effect of Support-Training System of Peer Group on Promotion of Self-Care in beta-Thalassemia Major Patients in Southern Iran.
    Hemoglobin. 2019;43:198-203.
    >> Share

  140. WANG MK, Shergill R, Jefkins M, Cheung J, et al
    A sickle cell disease patient with dural venous sinus thrombosis: a case report and literature review.
    Hemoglobin. 2019;43:193-197.
    >> Share

  141. YILMAZ S
    The Spectrum of beta-Thalassemia Mutations in Siirt Province, Southeastern Turkey.
    Hemoglobin. 2019;43:174-181.
    >> Share

  142. BORGES E, Tchonhi C, Couto CSB, Gomes V, et al
    Unusual beta-Globin Haplotype Distribution in Newborns from Bengo, Angola.
    Hemoglobin. 2019;43:149-154.
    >> Share

  143. YASSOUF MY, Alquobaili F, Kabalan Y, Mukhalalaty Y, et al
    Compliance with Deferoxamine Therapy and Thyroid Dysfunction of Patients with beta-Thalassemia Major in Syria.
    Hemoglobin. 2019;43:218-221.
    >> Share

  144. HASAN KN, Sufian A, Mazumder AK, Khaleque MA, et al
    A Novel Pathogenic beta-Thalassemia Mutation Identified at Codon 8 (HBB: c.27delG) in a Bangladeshi Family Acquired De Novo.
    Hemoglobin. 2019;43:162-165.
    >> Share

  145. ABDULLAH UYH, Ibrahim HM, Mahmud NB, Salleh MZ, et al
    Quadrupole-Time-of-Flight Mass Spectrometric Identification of Hemoglobin Subunits alpha, beta, gamma and delta in Unknown Peaks of High Performance Liquid Chromatography of Hemoglobin in beta-Thalassemias.
    Hemoglobin. 2019;43:182-187.
    >> Share

  146. HADIPOUR DEHSHAL M, Tabrizi Namini M, Hantoushzadeh R, Yousefi Darestani S, et al
    beta-Thalassemia in Iran: Things Everyone Needs to Know About This Disease.
    Hemoglobin. 2019;43:166-173.
    >> Share

    March 2019
  147. MORADI K, Aznab M, Tahmasebi S, Dastafkan Z, et al
    The Spectrum of alpha-Thalassemia Mutations in the Lak Population of Iran.
    Hemoglobin. 2019;43:107-111.
    >> Share

  148. JIT BP, Mohanty PK, Pradhan A, Purohit P, et al
    Erythrocyte cAMP in Determining Frequency of Acute Pain Episodes in Sickle Cell Disease Patients from Odisha State, India.
    Hemoglobin. 2019;43:88-94.
    >> Share

  149. ZHOU JY, Jiang F, Li J, Chen GL, et al
    Coinheritance of Hb City of Hope (HBB: c.208G>A) and beta-Thalassemia: Compromising the Molecular Diagnosis of the Codons 71/72 (+A) (HBB: c.216_217insA) Mutation by Reverse Dot-Blot Hybridization.
    Hemoglobin. 2019;43:145-147.
    >> Share

  150. HEIREMAN L, Luyckx A, Schynkel K, Dheedene A, et al
    Detection of a Large Novel alpha-Thalassemia Deletion in an Autochthonous Belgian Family.
    Hemoglobin. 2019;43:112-115.
    >> Share

  151. YANG K, Ren Q, Wu Y, Zhou Y, et al
    A Case of Hereditary Spherocytosis Caused by a Novel Homozygous Mutation in the SPTB Gene Misdiagnosed as beta-Thalassemia Intermedia Due to a KLF1 Gene Mutation.
    Hemoglobin. 2019;43:140-144.
    >> Share

  152. NGIM CF, Lee MY, Othman N, Lim SM, et al
    Prevalence and Risk Factors for Cardiac and Liver Iron Overload in Adults with Thalassemia in Malaysia.
    Hemoglobin. 2019;43:95-100.
    >> Share

  153. ADEKILE AD, Al-Sherida S, Marouf R, Mustafa N, et al
    The Sub-Phenotypes of Sickle Cell Disease in Kuwait.
    Hemoglobin. 2019;43:83-87.
    >> Share

  154. SUN M, Lou J, Zhag Y, Fu Y, et al
    Polymorphisms of alpha-Globin Genes Compromise Polymerase Chain Reaction-Based alpha-Thalassemia Genotyping in Three Chinese Families.
    Hemoglobin. 2019;43:101-106.
    >> Share

  155. XIE XM, Liu YN, Li J, Jiang F, et al
    A Kruppel-Like Factor 1 Gene Mutation Ameliorates the Severity of beta-Thalassemia: A Case Report.
    Hemoglobin. 2019;43:137-139.
    >> Share

    January 2019
  156. AZIMI A, Nejati P, Tahmasebi S, Alimoradi S, et al
    Characterization of the IVS-II-821 (A>C) (HBB: c.316-30A>C) Mutation in a beta-Thalassemia Phenotype in Iran.
    Hemoglobin. 2019;43:23-26.
    >> Share

  157. NUINOON M, Thipthara O, Fucharoen S
    Compound Heterozygote for a Novel Elongated C-Terminal beta-Globin Variant (HBB: c.364delG) and Hb E (HBB: c.79G>A) with Heterozygous alpha-Thalassemia-2.
    Hemoglobin. 2019;43:52-55.
    >> Share

  158. JIANG F, Li J, Zhou JY, Liao C, et al
    Regulatory Single Nucleotide Polymorphism rs368698783 (G>A): a Genetic Modifier of Hb F Production Only under Erythropoietic Stress Characteristic for beta-Globin Chain Deficiency?
    Hemoglobin. 2019;43:73-75.
    >> Share

  159. ALIBAKHSHI R, Moradi K, Aznab M, Azimi A, et al
    The Spectrum of beta-Thalassemia Mutations in Hamadan Province, West Iran.
    Hemoglobin. 2019;43:18-22.
    >> Share

  160. CURCIO C, Giannone V, Benzoni E, Cesaretti C, et al
    Hb Milano [alpha109(G16)Leu-->Pro (CTG>CCG); HBA1: c.329T>C]: A Novel Variant on the alpha1-Globin Gene in an Italian Family.
    Hemoglobin. 2019;43:4-6.
    >> Share

  161. SU Q, Chen S, Wu L, Tian R, et al
    Severe Thalassemia Caused by Hb Zunyi [beta147(HC3)Stop-->Gln; HBB: c.442T>C)] on the beta-Globin Gene.
    Hemoglobin. 2019;43:7-11.
    >> Share

  162. PARSAEE M, Pouraliakbar H, Azarkeivan A, Ghadrdoost B, et al
    The Role of Exercise Stress Echocardiography for Determination of Subclinical Cardiac Involvement in beta-Thalassemia Major.
    Hemoglobin. 2019;43:34-37.
    >> Share

  163. AGBUDUWE C, Rugless M, Asba N, Proven M, et al
    Severe Drug-Induced Hemolysis in a Patient with Compound Heterozygosity for Hb Peterborough (HBB: c.334G>T) and Hb Lepore-Boston-Washington (NG_000007.3: g.63632_71046del).
    Hemoglobin. 2019;43:56-59.
    >> Share

  164. KOLLIOPOULOU A, Siamoglou S, John A, Sgourou A, et al
    Role of Genomic Biomarkers in Increasing Fetal Hemoglobin Levels Upon Hydroxyurea Therapy and in beta-Thalassemia Intermedia: A Validation Cohort Study.
    Hemoglobin. 2019;43:27-33.
    >> Share

  165. INTASAI N, Phasit A, Panyasai S, Pornprasert S, et al
    A Case Report of Compound Heterozygosity for beta(0)/beta(+)-Thalassemia Resulting from under Diagnosed beta-Thalassemia Found in a Hb A'2 Sample.
    Hemoglobin. 2019;43:63-65.
    >> Share

  166. YAO X, Xu LH, Xu HG, Li XY, et al
    Iron Metabolism and Oxidative Status in Patients with Hb H Disease.
    Hemoglobin. 2019;43:38-41.
    >> Share

  167. BHAT A, Neculiseanu E, Tam EL, Gendy A, et al
    Purulent Pericarditis in Sickle Cell Disease Due to Streptococcus agalactiae; a Unique Case Report and Literature Review.
    Hemoglobin. 2019;43:1-3.
    >> Share

  168. MURAD H, Moassas F
    First Report on the Coinheritance of alpha-Thalassemia and a Rare beta-Thalassemia Compound Heterozygosity for the IVS-I-I(G>A)/IVS-II-705(T>G) Mutations in a Syrian Family.
    Hemoglobin. 2019;43:66-68.
    >> Share

  169. ZHAO Y, Lou J, Sun M, Fu Y, et al
    Hb H Disease Results from Compound Heterozygosity of - -(SEA) and -alpha(MAL3.5) in a Chinese Family.
    Hemoglobin. 2019;43:69-72.
    >> Share

  170. TAMADDONI A, Khabaz Astaneh S, Tabaripour R, Akhavan-Niaki H, et al
    Kruppel-Like Factor 1 Gene Mutations in Thalassemia Patients from North Iran: Report of a New Mutation Associated with beta-Thalassemia Intermedia.
    Hemoglobin. 2019;43:12-17.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016